Global Insomnia Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
MarketResearch.biz delivers in-depth insights on the global insomnia market in its upcoming report titled, “Global Insomnia Market Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global insomnia market is estimated to register a CAGR of X.X% in terms of value during the forecast period (2018–2027). The report offers in-depth insights, revenue details, and other vital information regarding the global insomnia, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global insomnia market report has been segmented on the basis of therapy type, drug formulation, diseases condition and region.
Insomnia, commonly known as sleeplessness or sleep deprivation, is a disorder wherein an individual is either unable to sleep or sleeps only partially or without adequate sleep. Insomnia affects quality of life and thought process as you feel unwell mentally and physically. Insomnia can affect people of any age and gender; however, it is more common in adult females and seriousness may increase during pregnancy, baby blues, and menopause. Insomnia is categorized into three types depending on the duration of the disorder, namely transient (few days), acute (few weeks), and chronic insomnia (few months or even years). Treatment of insomnia is given on the basis of condition or severity of disease. Common symptoms include obesity, concentration problems, reduced reaction time, memory related problems, poor immune system, daytime sleepiness, mood swings, anxiety, depression, and irritability.
Some causes of insomnia disorder include to disruption in circadian rhythm, chronic pain, hyperthyroidism, psychological stress, etc. Moreover, excessive use of drugs, such as caffeine, alcohol, and nicotine could lead to insomnia. These causes are the driving factors for growth of the global insomnia market. Other factors include technological advancements, rising demand for over-the-counter sleep aids, stressful lifestyle, job with extended periods of night shifts, environmental noise, extreme hot or cold conditions, hormonal changes, increasing number of mental disorders, Alzheimer’s and Parkinson’s disease, and sleeping next to snoring partner.
However, lack of awareness and education, and challenges in providing low-cost drugs coupled with highly competitive market for drugs, patent expiration, side-effects of drugs are major factors hampering market growth. As awareness regarding this condition grows, major potential can be tapped from a large undiagnosed insomnia population pool over the forecast period.
North America market accounts for major share in the global insomnia market, and is expected to maintain its dominance throughout the forecast period owing to technological advancements and rise in demand for over-the-counter drugs, followed by the market in Europe. Developing countries in Asia Pacific hold profitable opportunities for new entrants and existing vendors to invest in the countries of Asia Pacific with the elevating per capita income and upsurge in occurrence of insomnia disorder.
Global Insomnia Market is segmented and further sub-segmented as follows:
Global insomnia market, by types of therapy:
- Pharmacological Therapy
- Melatonin receptor agonists
- Non-pharmacological therapy
- Relaxation therapy
- Cognitive behavioral therapy
- Sleep hygiene education
- Stimulus control
- Paradoxical intention
Global insomnia market, by drug formulation:
Global insomnia market, by disorder type:
- Poor quality of sleep
- Sleep maintenance
Global insomnia market, by region:
- North America
- Asia Pacific
- Middle East & Africa
- Latin America
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Eisai Co.
- Pfizer Inc.
- Merck & Co. Inc.
- Sanofi Pasteur
- Takeda Pharmaceutical Company
- Meda Consumer Healthcare Inc.
- Pernix Therapeutics
- Purdue Pharma L.P.
- Consumer Healthcare Inc.
- Dainippon Sumitomo
- ECR Pharmaceuticals
- Flynn Pharma
- Johnson & Johnson
- Biocodex S A
- Vanda Pharmaceuticals Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!